Psychedelic API Market To Reach $6.1B By 2033 Boosted By LSD: New Analysis

February 10, 2023 · Benzinga

The psychedelic Active Pharmaceutical Ingredient (API) Market, currently estimated at $1.6 billion, is expected to rise at a CAGR of 13.2% over the next ten years and be worth $6.1 billion by the end of 2033.

That’s according to Persistence Market Research’s latest study, conducted by a team of experts in management, medicine and engineering.

“Increasing cGMP practices, growth in the pharmaceutical API manufacturing industry and increasing research on the impact of psychedelics on mental health are factors propelling the global market,” stated a Persistence Market Research analyst.

Past research located the worth of the global psychedelic market at $8.31 billion by 2028 and $12 billion by 2029.

The latest API report noted:

  • LSD APIs held 33.7% market share by product in 2022.
  • Novel synthetic compounds accounted for 42.2% share of the global psychedelic API market in 2022.
  • Synthetic sources held a share of 54.0% in the global market in 2022.
  • GMP-grade production held a market share of 97.8% in 2022.
  • By application, the research segment held a market share of 87.0% in 2022.
  • Around 33.3% of the global market share, by region, was accounted for by North America in 2022.

The study also presents a historical demand assessment of the period 2017-2022 and projections for the next ten years, through sections including products (API-grade psilocybin, DMT, LSD, MDMA, and ketamine), the API compound (active plant components, novel synthetic compounds, metabolites, isotopically labeled standards), source (natural, synthetic, bio-synthetic), grade (GMP, non-GMP), application (clinical, research), and considers key geographical regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa). (Full Story)

In categories:Business Psychedelics
Next Post

First NYS adult-use cannabis dispensary in Upstate NY, Southern Tier opens for business

BINGHAMTON, N.Y. — The first adult-use cannabis dispensary north of New York City opened for business Friday on Court Street in Binghamton. It's no short drive for Western New Yorkers, at seven hours round-trip, but it is half the distance…
Previous Post

Canopy Growth closing Tweed’s Smiths Falls facility, laying off 800 workers

The layoffs will represent 35 per cent of the company’s workforce. Forty per cent of the cuts will be immediate while the rest will take place over the course of the coming months. The former Hershey chocolate factory at 1 Hershey Drive…
Random Post

North Jersey entrepreneur to open weed dispensary at site of longtime funeral home

HALEDON — An entrepreneur from Bergen County is under contract to buy the decades-old funeral home on Belmont Avenue with a plan to open a cannabis dispensary there in a matter of months. Molly Ann Farms, a name borrowed from…
Random Post

Get Your Legal Weed Today: New Store Openings Across 6 States, Plus Canada

Trulieve Launches Rec Marijuana Sales In CT Trulieve Cannabis Corp.'s  TRULTCNNF new dispensary in Bristol, Connecticut, started selling adult-use cannabis products on Friday, Feb 17. Recently relocated to 820 Farmington Ave., the company's hybrid (medical and adult-use) dispensary will offer a large selection of…
Random Post

Canadian Cannabis Company Announces License to Sell Cocaine! - Nah, Never Mind, We Were Just Clickbaiting the World

Adastra Labs, a Langley-based company known for its cutting-edge cannabis and ethnobotanical products, has recently received approval from Health Canada for an amended license. This license permits the lawful possession, production, distribution, and sale of a highly regulated substance. Following…
Random Post


A brother-and-sister team convicted of trying to bribe a Northern California sheriff to protect family marijuana grows were sentenced Tuesday in Sacramento, but there were stark differences in the punishment each received. Gaosheng Laitinen, 41, a small shop owner in…